The Latest Breaking News from Nasdaq

Upgrades For E2open Parent Holdings Inc (NYSE:ETWO), Colliers Securities upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $14.58 and a 52-week-low of $7.66. E2open Parent Holdings closed at $9.37 at the end of the last trading period.

Mondelez International Inc - Class A's (NASDAQ:MDLZ) short percent of float has risen 29.87% since its last report. The company recently reported that it has 13.90 million shares sold short, which is 1.0% of all regular shares that are available for trading.

Gulf Island Fabrication (NASDAQ:GIFI) brought in sales totaling $25.81 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 210.84%, resulting in a loss of $5.89 million.

Benzinga Pro data, Codex DNA (NASDAQ:DNAY) reported Q4 sales of $3.08 million. Earnings fell to a loss of $12.49 million, resulting in a 27.15% decrease from last quarter.

Creative Medical Technology Holdings (NASDAQ:CELZ) has announced positive two-year follow-up data from its StemSpine pilot study. The data showed significant efficacy of the StemSpine procedure for treating chronic lower back pain without any serious adverse effects reported. StemSpine is a patented procedure that utilizes a patient's bone marrow aspirate to treat chronic lower…

Allogene Therapeutics Inc (NASDAQ: ALLO) announced the 

Benzinga Pro data, MaxCyte (NASDAQ:MXCT) reported Q4 sales of $10.15 million. Earnings fell to a loss of $4.87 million, resulting in a 81.85% decrease from last quarter.

According to Benzinga Pro data, during Q4, Exagen (NASDAQ:XGN) posted sales of $12.69 million. Earnings were up 1.76%, but Exagen still reported an overall loss of $7.05 million.

According to Benzinga Pro data, during Q4, DarioHealth (NASDAQ:DRIO) posted sales of $6.03 million. Earnings were up 3.82%, but DarioHealth still reported an overall loss of $21.59 million.